Search
forResearch 7 of 40
- Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab)
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
- BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer
- The impact of exercise on tolerability of systemic treatment in metastatic colorectal cancer: A literature review
- Therapeutic Strategies to Target the Androgen Receptor
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →